Nathaniel Chin
Host at Dementia Matters
Memory clinic doc @UWHealth. #Alzheimers and #dementia investigator @WisconsinADRC. Host of #DementiaMatters podcast. Grad of @uwsmph. #medtwitter #somedocs
Articles
-
2 months ago |
jamanetwork.com | Fred Ketchum |Nathaniel Chin |Joshua D. Grill |Neurological Disorders
Aligning Alzheimer Disease Biology With Care Two new proposals were recently made to incorporate advances in the diagnosis and staging of Alzheimer disease (AD) biomarkers into clinical practice.
-
Sep 23, 2024 |
madison.com | Nathaniel Chin
Fear keeps some people awake at night. Their parents or grandparents had Alzheimer’s disease. Whenever they struggled to remember people’s names or forgot why they walked into a room, they worried if they were developing it, too. While that fear is understandable, someone’s family history of Alzheimer’s does not paint a full picture of their own risk for developing the disease. Many people with a family history will never develop Alzheimer’s.
-
Feb 5, 2024 |
newsday.com | Nathaniel Chin
Fear and anxiety permeate the walls of the memory clinic where I work as a geriatrician. Patients and families dread the possibility of Alzheimer’s disease and a future they won’t recognize. Residents of Long Island — where studies show 1 in 8 seniors has Alzheimer's, a proportion higher than more than 70% of counties nationwide — share that concern. But it is not the disease that drives this worry; it’s the symptoms of dementia.
-
Nov 1, 2023 |
agsjournals.onlinelibrary.wiley.com | Nathaniel Chin |Eric Widera |Sharon Brangman |Jason Karlawish
The US Food and Drug Administration (FDA) approval of monoclonal antibodies (MAB) targeting amyloid protein for treatment of Alzheimer's disease has ushered in a new era in Alzheimer's care. Disease-modifying therapies are now available to patients living with cognitive impairment and confirmed presence of brain beta-amyloid. Many geriatricians have voiced concerns and even outright disagreement with their approval and clinical use.1, 2 Many of these concerns are valid.
-
Jul 17, 2023 |
jamanetwork.com | Eric Widera |Sharon Brangman |Nathaniel Chin
Ushering in a New Era of Alzheimer Disease Therapy Trial of Donanemab in Early Symptomatic Alzheimer Disease John R. Sims, MD; Jennifer A. Zimmer, MD; Cynthia D. Evans, PhD; Ming Lu, MD, MS, MPH; Paul Ardayfio, PhD; JonDavid Sparks, PhD; Alette M. Wessels, PhD; Sergey Shcherbinin, PhD; Hong Wang, PhD; Emel Serap Monkul Nery, MD; Emily C. Collins, PhD; Paul Solomon, PhD; Stephen Salloway, MD; Liana G.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 448
- Tweets
- 252
- DMs Open
- No
I’m excited to share this perspective essay in @NEJM. The role of primary care in evaluating cognitive change is critical. Biomarker testing is exciting, but it doesn’t simplify the process nor should it diminish the importance of a good history and clinical judgement.
As the number of people with dementia in the United States grows, many observers believe that diagnosis will have to happen in primary care. How can PCPs be prepared for this new and complex role? Perspective by Drs. @NathanielChinMD and @claireify_sci: https://t.co/XyuI5QqkHC https://t.co/jtlF9JPTlK
Thank you @ScottRobertsPhD for a great conversation on APOE testing and sharing results with research participants. Your insights will be helpful as the clinical field incorporates this testing more. The evaluation for using novel anti-amyloid therapies has brought many changes.
Genetics can play a significant role in one's risk for #Alzheimers, but how can people learn about their risk? @ScottRobertsPhD joins #DementiaMatters to discuss the importance of APOE disclosures, walk listeners through the process and more. Listen 🎧 https://t.co/oBjrnfrx8z https://t.co/Hj2L2MntOT
#Alzheimers affects an estimated 6.9 million Americans age 65 and older. If you appreciate the news, research and caregiver resources we provide on the #DementiaMatters podcast, consider donating to our fund through the @uwfoundation. Visit: https://t.co/7q5vYZq4JN https://t.co/xwbZnY9AjS
